X

AggregoTV

Top Videos
ESMO Vision stories of Integrated Cancer Care: Verna Vanderpuye, Ghana

"I think ESMO is poised to do that and I think we have a bright future ahead of us," says ESMO member Verna Vanderpuye from Ghana.

10/23/2020
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020

AggregoTV

`
What is the Evidence that Fecal Microbiota Transplantation Can Cure GvHD?

Mette Hazenberg, Amsterdam UMC discusses evidence that fecal microbiota transplantation can cure GvHD.

12/14/2020
Leukemia, Lymphoma, Myeloma, and Immunotherapy with Dr. Philip Greenberg

Dr. Philip Greenberg discusses how immunotherapy works for blood cancers, promising immunotherapy clinical trials, as well as potential side effects.

12/11/2020
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020
ESMO Vision Stories of Sustainable Cancer Care: Andrea Sbrana

Is statistically significant the same as clinically significant? The ESMO-MCBS has been thought to try and answer this question even when talking about newer treatments, explains Andrea Sbrana.

12/17/2020

AML

New Approaches for AML Patients Who Are Not Candidates for Intensive Therapy

Dr Stéphane de Botton discusses novel treatment approached for patients with acute myeloid leukemia who are not candidates for intensive therapy.

06/27/2021
The Role of MRD in AML

Dr Jacqueline Cloos talks on the role of measurable residual disease as a prognostic factor in the management of acute myeloid leukemia.

09/08/2021
How Molecular Testing Has Transformed AML Treatment Options

Dr David Sallman explains how molecular testing has transformed AML care, including a discussion of risk assessment and the role of next-generation sequencing.

09/05/2021
Treatment Cessation Using Venetoclax-Based Therapy for Older Patients With AML

Dr Andrew Wei discusses the combination of venetoclax with low-dose therapy as a new standard of care for older patients with AML who have not received prior treatment...

06/28/2021
The Importance of Induction Chemotherapy in the AML Treatment

Dr Jeffrey Lancet gives an overview of the importance of induction chemotherapy in the treatment of acute myeloid leukemia.

09/08/2021

DLBCL

IELSG30: Treating Primary Testicular DLBCL

Dr Annarita Conconi summarizes the results of the Phase II IELSG30 trial assessing R-CHOP, intravenous methotrexate, liposomal cytarabine, and scrotal irradiation in patients with primary DLBCL of the testis.

06/30/2021
First-in-Human Trial of ALLO-501A in R/R Large B-cell Lymphoma

Dr Michael Tees discusses the first-in-human data of ALLO-501A, an allogeneic CAR-T product under investigation in relapsed/refractory large B-cell lymphoma in the ALPHA2 study.

06/21/2021
Sequencing Treatment Options in Primary Refractory DLBCL

 

Davies begins by outlining a specific patient case, caveats in the current treatment options for DLBCL, and the patterns of primary refractory DLBCL.

06/25/2021
Which New Therapeutics Are Generating Excitement at This Year’s ICML?

Dr Salles summarizes preclinical data on a histone deacetylase inhibitor investigated for T-cell lymphoma, as well as data on bispecific antibodies investigated for DLBCL.

06/28/2021
R-CHOP Dose Intensity and Survival Outcomes in DLBCL

Chan Yoon Cheah, MBBS, discusses the results of a systematic review investigating the impact of R-CHOP dose intensity on survival outcomes in patients with DLBCL.

06/02/2021

Lung Cancer + Radiation Oncology

Future Perspectives on Radiation Oncology in Lung Cancer

Dr Umberto Ricardi discusses the management of patients with lung cancer who have brain metastases and the importance of precision medicine in treating these patients.

04/12/2021
Advances in Radiation Therapy in Stage III NSCLC

Oncology specialists from a lung multidisciplinary team discuss challenges associated with radiation therapy in Stage III NSCLC.

09/07/2021
Patterns of Relapse After Radiotherapy in SCLC and Future Treatment Strategies

Dr Sanjay Popat discusses the findings of a subset analysis of the CONVERT trial investigating patterns of relapse following thoracic radiotherapy in patients with limited-stage SCLC.

04/01/2021
Updates in Radiotherapy at ELCC 2021

In this discussion, Dr Umberto Ricardi outlines the latest developments in RT for patients with lung cancer, highlighting the ability to improve treatment of brain metastases with radiosurgery...

04/12/2021
Global Access to Radiotherapy for Lung Cancer

This webinar describes the current landscape and challenges to deliver RT for lung cancer, with an emphasis on low-and middle-income countries and geographically underserved regions of high-income countries.

09/22/2021

NSCLC

Sotorasib For KRAS G12C-Mutated Lung Cancer

Dr Sarah B. Goldberg discusses sotorasib for KRAS G12C-Mutated lung cancer.

08/24/2021
Lung Cancer Trial Updates at ASCO 2021

Dr Benjamin Besse discusses results from lung cancer trials that are anticipated in 2021.

06/23/2021
Predicting Outcomes of Advanced NSCLC Patients Treated With PD-1/PDL

Dr Gilberto de Lima Lopes Jr discusses "Predicting Outcomes of Advanced NSCLC Patients Treated With PD-1/PDL."

09/03/2021
WCLC 2020: Updates From the CHRYSALIS Trial And What it Means for Patients With NSCLC

In this expert discussion Dr Joshua Bauml and Dr Joshua Sabari speak about the updates from the CHRYSALIS trial and what it means for patients with NSCLC.

08/02/2021
5-Year Survival Outcomes From The PACIFIC Trial

Dr David R. Spigel presents five-year survival outcomes from the PACIFIC trial, a placebo-controlled Phase III study of patients with unresectable stage III NSCLC who were treated with durvalumab.

06/05/2021
Surgical Endpoints Are Needed in Lung Cancer Trials of Neoadjuvant Therapy

Dr Jonathan Spicer highlights the importance of introducing new endpoints in clinical trials of neoadjuvant approaches for lung cancer.

07/19/2021

Sickle Cell Anemia

Sickle Cell Disease Overview

Dr Kerry Morrone discusses what causes sickle cell disease, the signs, and symptoms and how to diagnosis it.

10/06/2021
Sickle Cell Disease: Ask Dr Susmita Sarangi

Dr Susmita Sarangi is a pediatric hematologist/oncologist in the MedStar Georgetown University Hospital Division of Pediatric, Adolescent, and Young Adult Hematology and Oncology.

09/27/2021
Clinical Research and Sickle Cell Disease

This discussion explores issues in sickle cell disease clinical research from the participant's perspective.

06/17/2021
Sickle Cell Disease and COVID-19

Dr John Whyte speaks with Dr Wanda Whitten-Shurney, CEO and Medical Director of the Michigan Chapter of the SCDAA, and Clifton R. Kirkman II, a sickle cell warrior, about the impact...

09/27/2021
NHS Approves 'Life Changing' Sickle Cell Disease Drug

A new treatment for sickle cell disease has been hailed as a "revolution" for sufferers. The condition is serious and lifelong and can cause severe pain and organ failure - and those who have it end up in hospital often.

10/05/2021
Spotlight
Colorectal Cancer and Immunotherapy with Dr. Scott Kopetz

Dr. Scott Kopetz discusses the latest breakthroughs and future promise of immunotherapy for colorectal cancer patients.

12/11/2020

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834